DyeVert™ PLUS

Taking Kidney Care to Heart

Revolutionary contrast reduction,
uncompromised imaging.

Have a Heart, Be Kind to Kidneys™

At Osprey Medical, our mission is to improve outcomes in patients with Chronic Kidney Disease by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs. Osprey’s proprietary technologies reduce the amount of contrast (dye) injected into patients during heart catheterization procedures without compromising X-ray image quality for the physician.

Learn more

We are Osprey Medical

Our vision is to make angiography safer for CKD patients.

Kidney Care – Reducing AKI in the Cath Lab

Kidney Care is about reducing AKI in the Cath Lab

Clinical Guidelines outline Kidney Care Protocols

Learn more

Uncompromised Dye Reduction

The only FDA indicated technology for reducing dye dosage to patients

Watch the video

DyeVert™ PLUS. Taking Kidney Care to Heart.

See the revolutionary technology indicated to reduce harmful contrast (dye) dosage delivered to patients.

Learn more

Watch the video

Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System

December 11, 2018

As part of Premier’s Technology Breakthroughs Program, Osprey Medical, Inc. has been awarded a group purchasing agreement giving Premier’s ~4,000 U.S. hospitals access to purchase the DyeVert Plus Contrast Reduction System. Osprey Medical’s DyeVert Plus System is the only technology cleared by the U. S. Food & Drug Administration for contrast reduction and real-time monitoring of dye dose delivered to patients during a coronary or peripheral angiogram. Use of the DyeVert Plus System has resulted in a mean 40% contrast media (dye) volume reduction, which has been shown to be statistically significant and clinically meaningful.

Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI)

September 20, 2018

Osprey Medical (ASX:OSP) is pleased to announce a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys™ campaign. The campaign aims to increase awareness of strategies to help address acute kidney injury (AKI) following normal heart imaging procedures (angiograms) in patients with chronic kidney disease (CKD). As part of the campaign, Osprey Medical and GE Healthcare will sponsor a number of educational programs and seminars for healthcare professionals on how to address the risk of AKI.

Photo credit (Kidney Care): Blausen.com staff (2014). “Medical gallery of Blausen Medical 2014“. WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.010. ISSN 2002-4436.